These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19852086)
1. [Biotechnology, the key to therapeutic innovation in the field of health]. Hoch D; Tambourin P Med Sci (Paris); 2009 May; 25 Spec No 2():13-7. PubMed ID: 19852086 [TBL] [Abstract][Full Text] [Related]
2. [Designing Genopole, a new concept and actor for science, technology and innovation policy in France]. Branciard A Med Sci (Paris); 2009 May; 25 Spec No 2():9-12. PubMed ID: 19852085 [TBL] [Abstract][Full Text] [Related]
3. Modern pharmaceutical biotechnology. Situation worldwide and in Germany 1995. Schlumberger HD; Stadler P Arzneimittelforschung; 1997 Jan; 47(1):106-10. PubMed ID: 9037455 [TBL] [Abstract][Full Text] [Related]
4. Future imperfect. Mackie P; Sim F Public Health; 2005 Feb; 119(2):75-6. PubMed ID: 15694953 [No Abstract] [Full Text] [Related]
5. India's health biotech sector at a crossroads. Frew SE; Rezaie R; Sammut SM; Ray M; Daar AS; Singer PA Nat Biotechnol; 2007 Apr; 25(4):403-17. PubMed ID: 17420744 [No Abstract] [Full Text] [Related]
6. The development of China's medical biotech industry needs to be driven by innovation. Yu Z; Dai Y Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752 [TBL] [Abstract][Full Text] [Related]
7. Why genetic competencies in public health and preventive medicine? Huang J Tenn Med; 2001 Apr; 94(4):131-4. PubMed ID: 11293338 [No Abstract] [Full Text] [Related]
8. [Biotechnologies should not build cathedrals of health technology]. Dine G Soins; 2001 May; (655):46. PubMed ID: 12008497 [No Abstract] [Full Text] [Related]
9. [State of unmet medical needs in France in 2006: necessity of reinforcing research effort]. Jouan-Flahault C; Billon N; Castaigne A; Henry YD; Omnes C; Puech A; Rosilio M; Lassale C Therapie; 2007; 62(5):393-415. PubMed ID: 18206102 [TBL] [Abstract][Full Text] [Related]
10. Much ado about gene patents: the role of foreseeability. Gulliford MJ Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032 [No Abstract] [Full Text] [Related]
11. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research]. Jaillon P Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783 [TBL] [Abstract][Full Text] [Related]
12. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector. Senker J; Enzing C; Joly PB; Reiss T Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596 [No Abstract] [Full Text] [Related]
13. Enabling Europe to innovate. Dearing A Science; 2007 Jan; 315(5810):344-7. PubMed ID: 17234939 [TBL] [Abstract][Full Text] [Related]
14. Genetic medicine. Powerful opportunities for good and greed. Dalzell MD Manag Care; 2001 May; 10(5):22-3, 27-8, 33-7. PubMed ID: 11392726 [No Abstract] [Full Text] [Related]
19. Your A to Z guide to the year in medicine. Bjerklie D; Gorman C; Park A; Song S Time; 2001 Jan; 157(2):105-12, 115. PubMed ID: 11195685 [No Abstract] [Full Text] [Related]